Abstract
We have adapted the surgical orthotopic implantation (SOI) model to image angiogenesis of human tumors labeled with green fluorescent protein (GFP) in nude mice. The nonluminous induced capillaries are clearly visible against the very bright tumor fluorescence examined either intravitally or by whole-body imaging in real time. The fluorescence shadowing replaces the laborious histological techniques for determining blood vessel density. Intravital images of an SOI model of human pancreatic tumors expressing GFP visualized angiogenic capillaries at both primary and metastatic sites. Whole-body optical imaging showed that blood vessel density increased linearly over a 20-week period in an SOI model of human breast cancer expressing GFP. Opening a reversible skin-flap in the light path markedly reduces signal attenuation, increasing detection sensitivity many-fold. The observable depth of tissue is thereby greatly increased. With dual-color fluorescence imaging, effected by using red fluorescent protein (RFP)-expressing tumors growing in GFPexpressing transgenic mice that express GFP in all cells, great clarity the details of the tumor-stroma interaction, especially tumor-induced angiogenesis are visualized. The GFP-expressing tumor vasculature, both nascent and mature, are readily distinguished interacting with the RFP-expressing tumor cells. Using a spectral imaging system based on liquid crystal tunable filters, we were able to separate individual spectral species on a pixel-by-pixel basis. Such techniques non-invasively visualized the presence of host GFPexpressing vessels within the RFP-labeled tumor by whole-body imaging. This new differential dual-colored fluorescence imaging tumor-host model, along with spectral unmixing, can non-invasively visualize in realtime the onset and progression of angiogenesis in a tumor. Thus, fluorescent proteins expressed in vivo offer the highest resolution and sensitivity for real-time whole-body imaging of angiogenesis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Carmeliet, P., 2003, Angiogenesis in health and disease. Nature Med 9:653–660.
Jain, R.K., 2003, Molecular regulation of vessel maturation. Nature Med 9:685–693.
Ruoslahti, E., 2002, Specialization of tumour vasculature. Na Rev Cancer, 2:83–90.
Hendrix, M. J., Seftor, E.A., Hess, A.R., and Seftor, R. E., 2003, Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat Rev Cancer 3:411–21.
McDonald, D.M., and Choyke, P.L., 2003, Imaging of angiogenesis: from microscope to clinic. Nat Med 9:713–725.
Yang, M., Baranov, E., Li, X-M., Wang, J-W., Jiang, P., Li, L., Moossa, A.R., Penman, S., and Hoffman, R.M., 2001, Whole-body and intravital optical imaging of angiogenesis in orthotopically implanted tumors. Proc Natl Acad Sci USA, 98:2616–2621.
Auerbach, R., Kubai, L., Knighton, D., and Folkman, J., 1974, A simple procedure for the long-term cultivation of chicken embryos. Dev Biol 41:391–394.
Crum, R., Szabo, S., and Folkman, J., 1985, A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science, 230:1375–1378.
Miller, J. W., Stinson, W. G., and Folkman, J., 1993, Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology, 100:9–14.
Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., and Martin, G. R., 1992, A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest, 67:519–528.
Alessandri, G., Raju, F., and Gullino, P. M., 1983, Mobilization of capillary endothelium in vitro induced by effectors of angiogenesis in vivo. Cancer Res, 43:1790–1797.
Deutsch, T. A., and Hughes, W. F., 1979, Suppressive effects of indomethacin on thermally induced neovascularization of rabbit corneas. Am J Ophthalmol, 87:536–540.
Korey, M., Peyman, G. A., and Berkowitz, R., 1977, The effect of hypertonic ointments on corneal alkali burns. Ann Ophthalmol, 9:1383–1387.
Mahoney, J. M., and Waterbury, L. D., 1985, Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea. Curr Eye Res, 4:531–535.
Li, W. W., Grayson, G., Folkman, J., and D'Amore, P. A., 1991, Sustained-release endotoxin. A model for inducing corneal neovascularization. Invest. Ophthalmol Vis Sci, 32:2906–2911.
Epstein, R. J., Hendricks, R. L., and Stulting, R. D., 1990, Interleukin-2 induces corneal neovascularization in A/J mice. Cornea, 9:318–323.
Gimbrone, M. A., Cotran, I. S., Leapman, S. B., and Folkman, J., 1974, Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst, 52:413–427.
Fournier, G. A., Lutty, G. A., Watt, S., Fenselau, A., and Patz, A., 1981, A corneal micropocket assay for angiogenesis in the rat eye. Invest Ophthalmol Vis Sci, 21:351–354.
Muthukkaruppan, V., and Auerbach, R., 1979, Angiogenesis in the mouse cornea. Science, 205:1416–1418.
Papenfuss, H. D., Gross, J. F., Intaglietta, M., and Treese, F. A., 1979, A transparent access chamber for the rat dorsal skin fold. Microvasc Res 18:311–318.
Gross, J., Roemer, R., Dewhirst, M., and Meyer, T., 1982, Int J Heat Mass Transfer, 25:1313–1320.
Dewhirst, M., Gross, J., Sim, D., Arnold, P., and Boyer, D., 1984, The effect of rate of heating or cooling prior to heating on tumor and normal tissue microcirculatory blood flow. Biorheology, 21:539–558.
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E. C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al., 1998, Tumor induction of VEGF promoter activity in stromal cells. Cell, 94:715–725.
Li, C. Y., Shan, S., Huang, Q., Braun, R. D., Lanzen, J., Hu, K., Lin, P., and Dewhirst, M. W., 2000, Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. J Natl Cancer Inst, 92:143–147.
Al-Mehdi, A. B., Tozawa, K., Fisher, A. B., Shientag, L., Lee, A., and Muschel, R. J., 2000, Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med, 6:100–102.
Huang, Q., Shan, S., Braun, R. D., Lanzen, J., Anyrhambatla, G., Kong, G., Borelli, M., Corry, P., Dewhirst, M. W., and Li, C. Y., 1999, Noninvasive visualization of tumors in rodent dorsal skin window chambers. Nat Biotechnol, 17:1033–1035.
Cowen, S. E., Bibby, M. C., and Double, J. A., 1995, Characterisation of the vasculature within a murine adenocarcinoma growing in different sites to evaluate the potential of vascular therapies. Acta Oncol, 34:357–360.
Hoffman, R.M., 2002, Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Lancet Oncology, 3:546–556.
O’ Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J., 1997, Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277–285.
Drevs, J., Hofmann, I., Hugenschmidt, H., Wittig, C., Madjar, H., Muller, W., Wood, J., Martiny-Baron, G., Unger, C., and Marme, D., 2000, Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Cancer Res, 60:4819–4824.
Prewett, M., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K., Overholser, J., Hooper, A., Pytowski, B., Witte, L., et al., 1999, Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res, 59:5209–5218.
Kurebayashi, J., Kunisue, H., Yamamoto, S., Kurosumi, M., Otsuki, T., and Sonoo, H., 2000, Paradoxical hormone responses of KPL-1 breast cancer cells in vivo: a significant role of angiogenesis in tumor growth. Oncology, 59:158–165.
Hoffman, R.M., 1999, Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Investigational New Drugs 17:343–359.
Yang, M., Baranov, E., Wang, J-W., Jiang, P., Wang, X., Sun, F-X., Bouvet, M., Moossa, A.R., Penman, S., and Hoffman, R.M., 2002, Direct external imaging of nascent cancer, tumor progression, angiogenesis, and metastasis on internal organs in the fluorescent orthotopic model. Proc Natl Acad Sci USA 99:3824–3829.
Okabe, M., Ikawa, M., Kominami, K., Nakanishi, T., and Nishimune, T., 1997, 'Green mice’ as a source of ubiquitous green cells. FEBS Letters, 407: 313–319.
Yang, M., Li, L., Jiang, P., Moossa, A.R., Penman, S., and Hoffman, R.M., 2003, Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc Natl Acad Sci USA, 100:14259–14262.
Levenson, R., Yang, M., and Hoffman, R.M., 2004, Whole-body dual-color differential fluorescence imaging of tumor angiogenesis enhanced by spectral unmixing. Proc Am Assoc Cancer Res, accepted abstract.
Yamamoto, N., Yang, M., Jiang, P., Xu, M., Tsuchiya, H., Tomita, K., Moossa, A.R., and Hoffman, R.M., 2003, Determination of clonality of metastasis by cell-specific color-coded fluorescent-protein imaging. Cancer Res, 63:7785–7790.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer
About this chapter
Cite this chapter
Hoffman, R.M. (2005). Imaging of Angiogenesis In Vivo with Fluorescent Proteins. In: Meadows, G.G. (eds) Integration/Interaction of Oncologic Growth. Cancer Growth and Progression, vol 15. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3414-8_3
Download citation
DOI: https://doi.org/10.1007/1-4020-3414-8_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-3413-8
Online ISBN: 978-1-4020-3414-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)